Teva Pharmaceutical Industries Limited (TEVA) Company Profile
Teva Pharmaceutical Industries Limited is a global pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. It has a global portfolio of approximately 1,000 molecules. Its central nervous system (CNS) portfolio includes Copaxone for the treatment of multiple sclerosis, Azilect for the treatment of the symptoms of Parkinson’s disease and Nuvigil for the treatment of sleep disorders, as well as several therapies for the treatment of pain care. Its main respiratory medicines include ProAir hydrofluoroalkane, QVAR and Duoresp Spiromax. Its oncology portfolio includes Treanda, Trisenox, Granix Synribo in the United States and Lonquex, Tevagrastim/Ratiograstim, Myocet, Trisenox and Eporatio outside the United States. Its women’s health portfolio includes ParaGard, Plan B One-Step OTC/Rx (levonorgestrel) and Zoely.
News about TEVA
Where Did Major Pharma Short Sellers Go?
Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Converse...Read More>>>
Pfizer's not the only drug company raising prices
Pfizer caved to pressure from President Donald Trump to temporarily roll back its drug price increases. But the pharmaceutical company isn't the only one hiking list prices in recent months. Until Pfizer's announcement Tuesday, few drug manufacturer...Read More>>>
Should You Wait for the DowDuPont Spinoff, or Is the Stock a Buy Now?
Today, DowDuPont (NYSE:DWDP) is a $155 billion industrial conglomerate. It operates in over 60 countries and is a global leader in agricultural technology, polymer manufacturing, and specialty materials used in electronics and food ingredients. By th...Read More>>>
Deckers Outdoor (DECK) Lowered to Buy at ValuEngine
Deckers Outdoor (NYSE:DECK) was downgraded by investment analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Friday. A number of other research analysts have also recently issued reports...Read More>>>
GCP Applied Technologies (GCP) versus Ashland Global (ASH) Critical Survey
GCP Applied Technologies (NYSE: GCP) and Ashland Global (NYSE:ASH) are both mid-cap construction companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendati...Read More>>>